-
Symbol
-
ERNA on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.005 per share
-
Latest Disclosed Shares Owned
-
6,211,530 shares
-
Security Ownership %
-
9.9%
Freebird Partners LP ownership in Ernexa Therapeutics Inc. Common Stock, par value $0.005 per share (ERNA)
14 May 2025 - Freebird Partners LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,211,530 shares of Ernexa Therapeutics Inc. Common Stock, par value $0.005 per share (ERNA).
This represents 9.9% ownership of the company.
In their previous filing dated 28 Jan 2025, Freebird Partners LP had reported owning 5,136,696 shares, indicating an increase of +21%.
.